Showing results (71-80 of 336) with videos related to
Sort By:
Pageof 34
Proceedings (Baylor University. Medical Center)|August 30, 2021
Severe babesiosis with associated splenic infarcts and aspleniaZachary A Sporn, Andrew Z Fenves, David B Sykes, et al.Journal of Thrombosis and Haemostasis : JTH|May 11, 2021
Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunologyHanny Al-Samkari, Alexandria Cronin, Donald M Arnold, et al.Research and Practice in Thrombosis and Haemostasis|September 1, 2021
Response to rituximab in children and adults with immune thrombocytopenia (ITP)Emily M Harris, Kirsty Hillier, Hanny Al-Samkari, et al.American Journal of Hematology|August 12, 2020
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19)Hanny Al-Samkari, Fei Song, Elizabeth M Van Cott, et al.American Journal of Hematology|July 2, 2025
Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic TelangiectasiaHanny Al-Samkari, Tracy J Mayne, Misty Troutt, et al.American Journal of Hematology|August 28, 2021
Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopeniaAndrew B Song, Katayoon Goodarzi, Rebecca Karp Leaf, et al.The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|February 5, 2020
Partial Suture Fusion in Nonsyndromic Single-Suture CraniosynostosisMichael K Boyajian, Hanny Al-Samkari, Dennis C Nguyen, et al.The Lancet. Haematology|March 3, 2022
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trialHanny Al-Samkari, Jaroslaw Kolb-Sielecki, Sufiia Z Safina, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 21, 2020
An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasiaHanny Al-Samkari, Hasan A Albitar, Scott E Olitsky, et al.Therapeutic Advances in Hematology|April 24, 2026
Efgartigimod as a treatment for adults with primary immune thrombocytopenia: a plain language summary of the ADVANCE IV studyCatherine Broome, Yoshitaka Miyakawa, Monica Carpenedo, et al.Pageof 34